Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium–glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin‐overloaded streptozotocin‐induced diabetic mice-Reference-Cited by-同舟云学术

Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium–glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin‐overloaded streptozotocin‐induced diabetic mice

Published:2022-03-09 Issue:6 Volume:13 Page:955-964
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Shimada Keiji¹^ORCID,Kanasaki Keizo¹²³^ORCID,Kato Makoto⁴⁵⁶,Ogura Yoshio¹,Takagaki Yuta¹,Monno Itaru¹,Hirai Taro¹^ORCID,Kitada Munehiro¹²^ORCID,Koya Daisuke¹²^ORCID

Affiliation:

1. Department of Diabetology and Endocrinology Kanazawa Medical University Kahoku‐gun Japan

2. Division of Anticipatory Molecular Food Science and Technology Medical Research Institute Kanazawa Medical University Uchinada Japan

3. Internal Medical 1 Faculty of Medicine Shimane University Izumo Japan

4. Ikuyaku. Integrated Value Development Division Mitsubishi Tanabe Pharma Corporation Osaka Japan

5. Naka Kinen Clinic Ibaraki Japan

6. Department of Cardiology International Medical Center Saitama Medical University Saitama Japan

Funder

Mitsubishi Tanabe Pharma Corporation

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13760

Reference32 articles.

1. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

2. Diabetic kidney disease

3. Macroalbuminuria Is a Better Risk Marker than Low Estimated GFR to Identify Individuals at Risk for Accelerated GFR Loss in Population Screening

4. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score–Matched Analysis of a Nationwide, Biopsy-Based Cohort Study

5. Sodium–glucose cotransporter-2 inhibitors for diabetic kidney disease: Targeting Warburg effects in proximal tubular cells